Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 134

1.

Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?

Kletenkov K, Hoffmann D, Böni J, Yerly S, Aubert V, Schöni-Affolter F, Struck D, Verheyen J, Klimkait T; Swiss HIV Cohort Study..

J Antimicrob Chemother. 2016 Dec 20. pii: dkw493. doi: 10.1093/jac/dkw493. [Epub ahead of print]

PMID:
27999036
2.

Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization.

Cecchinato V, Bernasconi E, Speck RF, Proietti M, Sauermann U, D'Agostino G, Danelon G, Rezzonico Jost T, Grassi F, Raeli L, Schöni-Affolter F, Stahl-Hennig C, Uguccioni M; Swiss HIV Cohort Study..

J Immunol. 2017 Jan 1;198(1):184-195.

3.

Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.

Bader J, Däumer M, Schöni-Affolter F, Böni J, Gorgievski-Hrisoho M, Martinetti G, Thielen A, Klimkait T; Swiss HIV Cohort Study..

Clin Infect Dis. 2017 Feb 1;64(3):295-300. doi: 10.1093/cid/ciw737.

PMID:
27838645
4.

Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.

Oberle CS, Joos B, Rusert P, Campbell NK, Beauparlant D, Kuster H, Weber J, Schenkel CD, Scherrer AU, Magnus C, Kouyos R, Rieder P, Niederöst B, Braun DL, Pavlovic J, Böni J, Yerly S, Klimkait T, Aubert V, Trkola A, Metzner KJ, Günthard HF; Swiss HIV Cohort Study (SHCS)..

Retrovirology. 2016 Sep 5;13(1):62. doi: 10.1186/s12977-016-0299-0.

5.

Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.

Ryom L, Lundgren JD, Ross M, Kirk O, Law M, Morlat P, Fontas E, Smit C, Fux CA, Hatleberg CI, de Wit S, Sabin CA, Mocroft A; D:A:D Study Group..

J Infect Dis. 2016 Oct 15;214(8):1212-20. doi: 10.1093/infdis/jiw342.

PMID:
27485357
6.

Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland.

Shilaih M, Marzel A, Yang WL, Scherrer AU, Schüpbach J, Böni J, Yerly S, Hirsch HH, Aubert V, Cavassini M, Klimkait T, Vernazza PL, Bernasconi E, Furrer H, Günthard HF, Kouyos R; Swiss HIV Cohort Study..

Sci Rep. 2016 Jun 14;6:27580. doi: 10.1038/srep27580.

7.

Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis.

Shilaih M, Marzel A, Scherrer AU, Braun DL, Kovari H, Rougemont M, Darling K, Battegay M, Hoffmann M, Bernasconi E, Hirzel C, Günthard HF, Kouyos RD; Swiss HIV Cohort Study a.; Swiss HIV Cohort Study..

J Infect Dis. 2016 Aug 15;214(4):599-606. doi: 10.1093/infdis/jiw195.

PMID:
27190182
8.

Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study.

Scherrer AU, Yang WL, Kouyos RD, Böni J, Yerly S, Klimkait T, Aubert V, Cavassini M, Battegay M, Hauser C, Calmy A, Schmid P, Bernasconi E, Günthard HF; Swiss HIV Cohort Study..

J Infect Dis. 2016 Aug 1;214(3):399-402. doi: 10.1093/infdis/jiw165.

PMID:
27130429
9.

HIV-Positive-to-HIV-Positive Liver Transplantation.

Calmy A, van Delden C, Giostra E, Junet C, Rubbia Brandt L, Yerly S, Chave JP, Samer C, Elkrief L, Vionnet J, Berney T; Swiss HIV and Swiss Transplant Cohort Studies..

Am J Transplant. 2016 Aug;16(8):2473-8. doi: 10.1111/ajt.13824.

PMID:
27109874
10.

Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.

Barceló C, Gaspar F, Aouri M, Panchaud A, Rotger M, Guidi M, Cavassini M, Buclin T, Decosterd LA, Csajka C; Swiss HIV Cohort Study..

J Antimicrob Chemother. 2016 Jul;71(7):1933-42. doi: 10.1093/jac/dkw050.

PMID:
27029846
11.

Correlating HIV tropism with immunological response under combination antiretroviral therapy.

Bader J, Schöni-Affolter F, Böni J, Gorgievski-Hrisoho M, Martinetti G, Battegay M, Klimkait T; Swiss HIV Cohort Study..

HIV Med. 2016 Sep;17(8):615-22. doi: 10.1111/hiv.12365.

PMID:
26991140
12.

Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis.

Scherrer AU, von Wyl V, Yang WL, Kouyos RD, Böni J, Yerly S, Klimkait T, Aubert V, Cavassini M, Battegay M, Furrer H, Calmy A, Vernazza P, Bernasconi E, Günthard HF; Swiss HIV Cohort Study.; Swiss HIV Cohort Study..

Clin Infect Dis. 2016 May 15;62(10):1310-7. doi: 10.1093/cid/ciw128.

PMID:
26962075
13.

Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.

Podlekareva DN, Efsen AM, Schultze A, Post FA, Skrahina AM, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Miro JM, Vassilenko A, Girardi E, Bruyand M, Obel N, Lundgren JD, Mocroft A, Kirk O; TB:HIV study group in EuroCoord..

Lancet HIV. 2016 Mar;3(3):e120-31. doi: 10.1016/S2352-3018(15)00252-0.

PMID:
26939735
14.

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.

De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D; CHAIN and COHERE in EuroCoord..

J Antimicrob Chemother. 2016 May;71(5):1352-60. doi: 10.1093/jac/dkv465.

PMID:
26825119
15.

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.

Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study..

Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8.

PMID:
26762990
16.

Reasons for late presentation to HIV care in Switzerland.

Hachfeld A, Ledergerber B, Darling K, Weber R, Calmy A, Battegay M, Sugimoto K, Di Benedetto C, Fux CA, Tarr PE, Kouyos R, Furrer H, Wandeler G; Swiss HIV Cohort Study..

J Int AIDS Soc. 2015 Nov 18;18:20317. doi: 10.7448/IAS.18.1.20317.

17.

In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid.

Aouri M, Barcelo C, Ternon B, Cavassini M, Anagnostopoulos A, Yerly S, Hugues H, Vernazza P, Günthard HF, Buclin T, Telenti A, Rotger M, Decosterd LA; Swiss HIV Cohort Study..

Drug Metab Dispos. 2016 Jan;44(1):151-61. doi: 10.1124/dmd.115.065839.

18.

Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.

Clifford GM, Franceschi S, Keiser O, Schöni-Affolter F, Lise M, Dehler S, Levi F, Mousavi M, Bouchardy C, Wolfensberger A, Darling KE, Staehelin C, Bertisch B, Kuenzli E, Bernasconi E, Pawlita M, Egger M; Swiss HIV Cohort Study..

Int J Cancer. 2016 Apr 1;138(7):1732-40. doi: 10.1002/ijc.29913.

PMID:
26537763
19.

Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS).

Anagnostopoulos A, Ledergerber B, Jaccard R, Shaw SA, Stoeckle M, Bernasconi E, Barth J, Calmy A, Berney A, Jenewein J, Weber R; Swiss HIV Cohort Study..

PLoS One. 2015 Oct 22;10(10):e0140943. doi: 10.1371/journal.pone.0140943.

20.

The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events.

Wandeler G, Kraus D, Fehr J, Conen A, Calmy A, Orasch C, Battegay M, Schmid P, Bernasconi E, Furrer H; Swiss HIV Cohort Study..

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):302-9. doi: 10.1097/QAI.0000000000000864.

Items per page

Supplemental Content

Loading ...
Support Center